|
|
|
|
|
SRV Fund Portfolio
|
|
 |
|
|
Dimerix is using its G-Protein Coupled Receptor - Heterodimer Identification Technology (GPCR-HIT) to develop the next generation of drugs targeting G-Protein Coupled Receptors. |
|
|
Matteo Mining is a mining technology company commercializing a novel underground mining and tunneling system that promises to disrupt the economics of coal and other sub-surface mining operations |
|
|
Orthocell is a world leading regenerative medicine company commercializing therapies for tendon and ligament tissue repair and regeneration, as well as a new collagen based scaffold for orthopaedic and general surgical repairs and augmentation. |
|
|
|
|
|
|
|